TotalMarketCap

Zai Lab

ZLABNasdaq ChinaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.539 B

$22.62 -0.79%

Close of 6 Nov 2026

As of 6 Nov 2026, Zai Lab (ZLAB) has a market capitalization of $2.54B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$460.2M

#1934 by revenue

Earnings

-$175.5M

Loss-making

Shares outstanding

1,124,322,530

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #78XencorXNCR$2.56B
  2. #79Arcus BiosciencesRCUS$2.55B
  3. #80Zai LabZLAB$2.54B
  4. #81HUTCHMED (China)HCM$2.48B
  5. #82Palvella TherapeuticsPVLA$2.48B

What if Zai Lab were worth as much as…

Open the what-if tool →

Gold $28.2T

$251,517.08

Per share 11,119× higher

Bitcoin $1.53T

$13,609.15

Per share 602× higher

Apple $5.02T

$44,677.57

Per share 1,975× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Zai Lab are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.